Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 5.6B | 5.4B | 4.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.0B | 2.0B | 2.0B | 1.9B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.8B | 1.9B | 1.9B | 1.8B |
Tax provision | 347M | 278M | 357M | 342M |
Net income | 1.5B | 1.6B | 1.5B | 1.5B |
Basic EPS | 3.5 | 3.8 | 3.5 | 3.4 |
Diluted EPS | 3.5 | 3.8 | 3.5 | 3.4 |
Basic average shares | 441.7M | 442.8M | 442.8M | 443.9M |
Diluted average shares | 441.7M | 442.8M | 443.9M | 443.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.5B | 1.6B | 1.5B | 1.5B |
Minority interests | -18M | -17M | -15M | -18M |
Preferred stock dividends | 11M | 11M | 12M | 9M |